Qiming Venture Partners
启明创投
Qiming Venture Partners is a Chinese venture capital firm founded in 2006 by founding managing partner Duane Kuang, focused on early- and growth-stage companies in technology and healthcare . As described in its own mid-2026 materials, it manages 11 USD funds and 7 RMB funds totaling $9.5 billion, has backed over 580 companies, seen more than 210 of them list or exit via M&A, and counts over 80 recognized unicorns in the portfolio . Its best-known wins span the consumer-internet era — Xiaomi, Meituan, Bilibili, Zhihu — and an increasingly industrial and healthcare-heavy book including Zai Lab, Insilico Medicine, and WeRide . As 暗涌Waves framed it when Qiming raised a record 6.5 billion RMB fund in 2023, the firm has ridden multiple cycles from internet bets into pharma and hard tech, with Kuang insisting scale was never the goal .
AI-generated — may contain errors, please verify.
Coverage
Qiming Venture Partners Donates to Support Rescue and Reconstruction Efforts After Tibet Gyirong Mudslide Disaster
Supporting the Tibet Autonomous Region Charity Federation in disaster relief and post-disaster reconstruction efforts, providing emergency rescue and long-term assistance to affected populations.
Qiming Venture Partners Weekly: Top 10 Portfolio Company Updates Vol. 28, Sep. 2, 2026
Celebrating milestone moments with Qiming Venture Partners' portfolio companies
Qiming Star | StepFun's Yibo Zhu: In the Agent Era, AI Infrastructure Must Optimize Intelligence, Speed, and Cost | WAIC 2026
In the Agent era, the core objective of AI infrastructure is shifting from merely reducing inference costs to simultaneously optimizing for intelligence, speed, and cost.
Qiming Weekly | Top 10 Updates from Qiming Venture Partners Portfolio Vol.27, 2026.8.26
Celebrating milestone moments with Qiming Venture Partners' portfolio companies.
Morning Star | Shengshu Technology's Luo Yihang: From Understanding Language to Understanding the World, General World Model Opens a New Chapter in AI Development | WAIC 2026
AI is moving from understanding and generating the digital world to understanding and acting in the physical world, and world models are the foundational infrastructure driving this transformation.
Qiming Venture Partners' Alex Zhou: Riding the Tech Wave to Find AI's Commercial Inflection Point | WAIC 2026
Stick to the "half-step ahead" investment methodology, and only invest within your circle of competence.
Qiming Star | Enginprime Medical Closes Nearly 100 Million Yuan Series A Round, Solely Invested by Qiming Venture Partners
J&T Global Express focuses on the percutaneous ventricular assist device (pVAD) track, dedicated to developing a new generation of small-size, high-flow ventricular assist systems.
Qiming Venture Partners' Alex Zhou: At the 'Everest Base Camp,' Foreseeing the Path to Kingship for AI Startups
Artificial intelligence is undergoing a profound shift from "bolt-on" to "built-in," from spectacle to commercial deployment.
Qiming Venture Partners and Portfolio Companies Win 2026 Golden Eagle Venture Capital and Sci-Tech Innovation Seedling Awards
Continuously identifying outstanding leaders in the venture capital and startup space, while witnessing entrepreneurial ventures grow from tender "new shoots" into towering trees.
Qiming Star | Chinese Chassis-by-Wire Leader Nexteer Technology Successfully Lists on Hong Kong Exchanges and Clearing Limited
Qiming Venture Partners co-led NaSen Technology's Series A round in 2018 and continued to back the company in its Series B round.
Qiming Star | Immune-Mediated Disease Leader Attovia Therapeutics Debuts on Nasdaq | Bilingual
Focused on developing next-generation biotherapeutics for immune-mediated diseases with significant unmet clinical needs.
Morning Star | Spotlight Moment! Qiming Venture Partners and Portfolio Companies Win Major Awards at WAIC 2026
Including the 2026 AI Person of the Year, the Yunfan Award, the WAIC Future Tech α³⁵ Young Leaders list, the World Artificial Intelligence Conference's highest honor — the SAIL Award — as well as the "Treasure of the Pavilion" and other major award winners.
Blue Emergence raises tens of millions of RMB in angel+ round co-led by Qiming Venture Partners
Ocean-tech consumer products company
Morning Star | A Look Back: The Exhibits and Talks You Couldn't Get Enough of at WAIC 2026
Several portfolio companies of Qiming Venture Partners demonstrated their technological innovation capabilities and growth potential through forums, core technology showcases, and thought leadership on cutting-edge trends.
Qiming Venture Partners | WAIC Qiming Venture Partners Entrepreneurship and Investment Forum—The Evolution from Computing Power Origin to Application Success Held in Shanghai
As one of the most forward-looking and influential venture capital firms in artificial intelligence, Qiming Venture Partners has hosted this forum for four consecutive years. It is also the only forum at this year's World Artificial Intelligence Conference initiated by a venture capital firm, designed to showcase and explore the latest breakthroughs in AI's evolution from underlying computing power to industrial application — all through the lens of innovation.
Livestream Registration | Today! 2026 WAIC Qiming Venture Partners Entrepreneurship and Investment Forum: The Evolutionary Journey from Computing Power Origin to Application Deployment
Decoding the Paradigm Shift in the LLM Era Together: How the Industry Can Move Beyond Pure Parameter Chasing to Ruthless Exploration of Real-World Scenarios, Cost Efficiency, and Closed-Loop Business Models
One Day to Go: 2026 WAIC Qiming Venture Partners Entrepreneurship and Investment Forum — The Evolution From Computing Power to Application Set to Open
Decoding the Paradigm Shift in the LLM Era: How the Industry Can Move Beyond Pure Parameter Chasing Toward Ruthless Exploration of Real-World Scenarios, Cost Efficiency, and Closed-Loop Business Models
Guest Lineup Revealed | 2026 WAIC Qiming Venture Partners Entrepreneurship & Investment Forum: The Evolution from Computing Power Origin to Application Deployment
Decoding the Paradigm Shift in the Large Model Era: How the Industry Can Move Beyond Pure Parameter Chasing to Ruthless Exploration of Real-World Scenarios, Cost Efficiency, and Closed-Loop Business Models
Agenda Unveiled | 2026 WAIC Qiming Venture Partners Entrepreneurship and Investment Forum: The Evolutionary Journey from Computing Power Origin to Application Landing
Decoding the Paradigm Shift in the LLM Era: How the Industry Can Move Beyond the Pursuit of Parameters to Ruthlessly Explore Real-World Scenarios, Cost Efficiency, and Closed-Loop Business Models
Qiming Weekly | 10 Updates from Qiming Venture Partners Portfolio Vol.23, 2026.7.7
Staying with you through the milestone moments of Qiming Venture Partners' portfolio companies.
Qiming Star | MedLinkTherapeutics' Xue Tongtong: In ADC's Blue Ocean Era, the Pragmatic Will Prevail
Yili Biotech Could Become the Next Big Pharma
Qiming Weekly | Top 10 News from Qiming Venture Partners' Portfolio Companies Vol.21, 2026.6.23
Celebrating milestone moments with Qiming Venture Partners' portfolio companies
Qiming View | William Hu: Globalization of China's Healthcare Innovation Just Beginning, Will Be Investment Theme for Next 10-20 Years
China's healthcare innovation globalization has only just begun, and it will remain a sustained investment theme for the next 10-20 years.
Qiming Venture Partners Weekly | Top 10 Portfolio Company Updates Vol.19, June 9, 2026
Staying with you through the milestone moments of Qiming Venture Partners' portfolio companies
Qiming View | Qiming Venture Partners' Kan Chen: Leading Two Consecutive Rounds for Ticen Biotech, Firmly Committed to Cutting-Edge Medical Innovation
Qiming Venture Partners remains steadfast in its focus on addressing unmet clinical needs and consistently pursues cutting-edge healthcare innovations with global competitiveness.
Qiming Venture Partners Portfolio Company Tiachen Biologics, a Leader in Allergy and Autoimmune Innovative Drugs in China, Successfully Lists on Hong Kong Exchanges and Clearing Limited
In 2024, Qiming Venture Partners led TianChen Bio's Series B2 round, and then co-led the company's Series C round in 2025.
Qiming Weekly | Top 10 News from Qiming Venture Partners Portfolio Vol.18, 2026.6.2
Celebrating milestone moments with Qiming Venture Partners' portfolio companies
Qiming Venture Partners' William Hu: China Is Seeing the Birth of a Wave of Global Pharmaceutical Companies
Over the next five to ten years, more highly original R&D breakthroughs are expected to emerge from labs in China and contribute to global pharmaceutical innovation.
Qiming Toutiao | Qiming Venture Partners' Alex Zhou Named to Forbes 2026 Midas List of World's Top Venture Capitalists
The systematic capabilities Qiming Venture Partners has built over nearly two decades: long-term conviction focused on two core sectors, a systematic "half-step ahead" deployment strategy, and full-chain expertise spanning early to growth stages.
Qiming View | Alex Zhou and Chen Nan of Qiming Venture Partners: Witnessing Yunyinggu Technology Team's Exponential Growth, Staying 'Half a Step Ahead' Through Long-Termism
Qiming Venture Partners' investment strategy is becoming increasingly focused, staying committed to deepening its existing circle of competence and building out its portfolio with steady, deliberate execution.
Morning Star | China Display Chip Design Leader Yunyinggu Technology Lists on Hong Kong Exchanges and Clearing Limited | Bilingual
As early as 2019, Qiming Venture Partners led Yunyinggu's Series C round and continued to back the company in its subsequent Series D financing.
Qiming Weekly | Top 10 Updates from Qiming Venture Partners Portfolio Companies Vol.17, 2026.5.26
Celebrating milestone moments with Qiming Venture Partners' portfolio companies
Qiming Venture Partners and Nearly 40 Portfolio Companies Named to VBData 2026 Future Healthcare 100
China's most authoritative and influential innovation benchmark for the healthcare industry
Qiming Venture Partners' Duane Kuang: Embrace and Navigate Cycles, AI Will Be an Ultra-Long Technology Cycle
Our primary focus is the technology development cycle, and we structure our investments around this cycle as the central thread.
Qiming Venture Partners' Ye Guantai: In the AI Era, Super Returns Belong Only to Non-Consensus Companies
For the next ten years, China will remain the global center of consumer hardware innovation.
Qiming Venture Partners' Kan Chen: NewCo Model Profoundly Impacts Global Value of Chinese Innovative Drugs
This isn't just a successful investment case — it more profoundly reveals the path by which China's pharmaceutical innovation is being revalued.
Morning Star | Lixue Xia on Building the 'Most Efficient Token Factory'
China will become the world's "token factory" in the future. In the past, Made in China meant manufacturing. Now, it's AI Made in China.
Qiming Venture Partners' Wang Shiyu: AI App Explosion Needs a Huge Business Model Overhaul
The real explosion of consumer-facing AI applications may require a massive shift in business models to make it happen.
Qiming Venture Partners Weekly | Top 10 Portfolio Company Updates Vol.15, April 28, 2026
Staying with you to mark the milestone moments of Qiming Venture Partners' portfolio companies
Qiming Weekly | Top 10 Updates from Qiming Venture Partners Portfolio Companies Vol.14, 2026.4.21
Staying with you to mark the milestone moments of Qiming Venture Partners' portfolio companies.
Qiming Venture Partners-backed precision proteomics leader Alamar Biosciences debuts on Nasdaq
Qiming Venture Partners led Alamar Biosciences' Series A round in 2020, and continued to back the company in its Series B and C rounds.
Qiming Weekly | Top 10 News from Qiming Venture Partners Portfolio Companies Vol.13, 2026.4.14
Celebrating milestone moments with Qiming Venture Partners' portfolio companies
Qiming Venture Partners Portfolio Companies Dominate 2025 New Economy Top 500 List
This ranking systematically maps the landscape, growth momentum, and evolutionary trajectory of China's new economy enterprises.
OriCell Therapeutics Announces $110 Million Pre-IPO Round, Co-Led by Qiming Venture Partners
Global leader in innovative tumor immunotherapy
Qiming Weekly | Top 10 Updates from Qiming Venture Partners Portfolio Companies Vol.12, 2026.4.7
Staying with you to mark the milestone moments of Qiming Venture Partners' portfolio companies.
Qiming Stars | Pusillabio's Song Yangzhou: Using a Single Swab to Make the 'Top Killer' Nowhere to Hide
The value of a technology isn't determined on the day it's launched, but on every day thereafter — when it's repeatedly tested, refined, and put to use again and again.
Qiming Venture Partners Exclusively Leads Medway Medical's Series C Financing
a leading player in China's disposable endoscope market
AlphaLeads | Financial AI frontrunner Xuntu Technology (AlphaPai) closes nearly RMB 200 million Series A led by Qiming Venture Partners
Pioneer in Financial AI
Qiming Star | Tashi Zhihang CEO Yilun Chen Makes GTC Debut: Globally Unveils AWE 3.0, the First General-Purpose Embodied Large Model That Can Actually Work, Establishing New Path for Physical AI
AWE 3.0's design goals are clear and pragmatic — to get robots truly "out of the greenhouse, onto the job site, and capable of generalizing across tasks."
Qiming Weekly | Top 10 News from Qiming Venture Partners Portfolio Companies Vol.10, 2026.3.24
Celebrating milestone moments with Qiming Venture Partners' portfolio companies
Qiming Venture Partners and Its Investors Named to Diyixinsheng's 2025 China Investment Institutions and Individuals Rankings
Designed to unearth a genuine "founder's guide to fundraising, an LP's investment reference."
CODE27 Raises Over $10 Million, Led by Qiming Venture Partners
Building an immersive interaction platform dedicated to exclusive AI characters.
Qiming Weekly | Top 10 News from Qiming Venture Partners Portfolio Vol.09, 2026.3.17
Celebrating milestone moments with Qiming Venture Partners' portfolio companies
Qiming Venture Partners' Duane Kuang: Investing in AI Is China's Biggest Certainty for the Next 20 Years
Over the past two decades, the venture capital industry has seen its share of ups and downs. We've consistently responded to change by staying true to our core principles: first, an unwavering conviction in China's long-term growth potential and a deep commitment to the Chinese market; second, a steadfast focus on innovation-driven strategies.
Qiming Venture Partners and Portfolio Company Female Leaders Win Multiple Awards
The list and its curation aim to celebrate women's contributions and achievements in China's equity investment sector and to the Chinese economy.
Qiming Venture Partners Weekly | Top 10 Portfolio News Vol.08, 2026.3.10
Staying with you through milestone moments at Qiming Venture Partners portfolio companies
Qiming Venture Partners Wishes You a Happy Lantern Festival of Harmony, Fulfillment, and Good Fortune
A New Year Dawns; Spring's Tidings Have Arrived
Qiming Venture Partners Co-Leads Nearly 100 Million Yuan Series C Round in Raincong Biotech
J&T Global Express has built a world-leading medical hydrogel technology platform, dedicated to providing innovative medical device solutions for major clinical scenarios such as tumor treatment.
Qiming Venture Partners | Pusilihua Founder Professor Song Yangzhou Named to TIME100 Health 2026 List of World's Most Influential People in Health
In the official selection rationale released by TIME, the focus was on the extraordinary contributions that Professor Songyang Zhou and his team at Pusillabio have made in the field of tuberculosis detection.
Qiming Venture Partners Portfolio Company Zhipu AI Open-Sources GLM-5: From Code to Engineering, the Best Open-Source Model for the Agentic Engineering Era
On the authoritative global Artificial Analysis benchmark, GLM-5 ranks fourth worldwide and first among open-source models.
Qiming View | Three AI IPOs in First Weeks of Year: Qiming Venture Partners' Alex Zhou on Following Power Law, Betting on Long Slopes and Big Tracks in Tech
To Alex Zhou, an IPO is a staging ground — a place to face tougher challenges, build up strength and resources, and prepare to strike.
Qiming Venture Partners Weekly · Top 10 Portfolio News, Vol. 05, 2026.2.11
Staying with you through the milestone moments of Qiming Venture Partners' portfolio companies
Qiming Venture Partners | Global Top Biotech VCs Gather, First S2S China Symposium Startup Proposal Countdown Begins
Top scientists are invited to visit the S2SChina website and submit proposals, embarking on an accelerated journey from the lab to entrepreneurship.
Qiming Star | China's Edge AI Chip Leader Aixin Yuanzhi Debuts on Hong Kong Exchanges and Clearing Limited
Qiming Venture Partners led Aixin Yuanzhi's Pre-A funding round in early 2020, becoming the company's earliest investor, and continued to support the company's growth in two subsequent funding rounds.
Qiming Venture Partners' Alex Zhou: AXERA's "Chip and AI" Expertise and Platform Strategy Built Its Success
Qiming Venture Partners has landed its third AI-related IPO in less than 40 days since the start of 2026.
Qiming Venture Partners Portfolio Company Northmed Technology Debuts on STAR Market
In 2020, Qiming Venture Partners led the Series C round for NorthSea Therapeutics and continued to support the company's growth in its Series D round.
Qiming Venture Partners' Zhang Ao: Six Years with NorthMed, Strong Confidence in China Healthcare Innovation Fundamentals
From Qiming Venture Partners' perspective, an increasing number of Chinese medical innovations are demonstrating internationally leading clinical value, and their global competitiveness is rapidly rising.
Qiming Venture Partners and Its Investors Win Multiple Awards on China FOF Research Center 2025 Annual Rankings
This is intended to encourage outstanding institutions and talent in private equity fund-of-funds and the broader fund industry, and to promote the healthy development of equity investment.
Qiming Venture Partners and Peking University Launch "Building Global Consensus on AI Guardrails" Initiative
Build a shared framework for dialogue among industry, professional communities, and policymakers based on common understanding, driving the formation of foundational international norms of conduct.
Qiming Venture Partners Wins Six Awards on TMTpost 2025 Annual Pioneer List
China's venture capital market has entered a recovery channel, buoyed by the flood of AI.
Oricell Therapeutics Closes First Tranche of $70M Series C to Accelerate Global Development of Solid Tumor CAR-T Therapies
A global leader in innovative tumor immunotherapy
Qiming Venture Partners' Alex Zhou: Zhipu AI's Successful IPO Is a Huge Confidence Boost for China's Long-Term Sectors
Qiming Venture Partners adheres to a "half-step ahead" investment methodology: positioning itself before a major wave coalesces into explicit consensus, yet not so early that it enters purely unconverged scientific exploration. This demands deep industry understanding from the firm and a powerful "radar" network to capture convergence signals.
Morning Star | Zhipu AI, a Pioneer and Leader in China's AGI, Successfully Lists on Hong Kong Exchanges and Clearing Limited | Bilingual
Qiming Venture Partners co-led Zhipu AI's Series B1 round in early 2022 — nearly a year before ChatGPT's release ignited the global large language model wave. It was this funding that enabled Zhipu AI to push through the R&D of its first 100-billion-parameter model, GLM. Qiming Venture Partners continued to back the company in its Series B2 and B4 rounds.
Qiming Venture Partners and Its Investors Win Seven Awards Including Top 10 Best IPO Investment Institutions of 2025 by IPO Zao Zhi Dao
We hope to highlight investment firms that were bolder in their early-stage bets and backed projects that exerted greater influence on their industries and the market at large.
Qiming Star | Biren Technology, Leading Domestic GPU Company, Successfully Lists on Hong Kong Exchanges and Clearing Limited | Bilingual
Qiming Venture Partners was one of Biren Technology's earliest and most steadfast supporters. When Biren Technology was founded in 2019, Qiming Venture Partners came in as a founding investor, leading the company's first funding round, and has continued to back the company's growth ever since.
Qiming Venture Partners' Alex Zhou: From Founding Investor to IPO Cornerstone, Firmly Believing in Biren Technology's Ability to Navigate Long Cycles
"We won't invest too early before the wave arrives, nor will we follow the crowd once the wave has fully formed. We aim to seize the moment — that 'half-step' just before the big wave hits — to find and back the most promising teams."
Qiming Venture Partners Wins Eight Awards in Zero2IPO's 2025 Rankings, Including Third Place Among China's Top VC Firms
The ranking aims to provide a robust evaluation and reference framework for China's equity investment industry.
Qiming Venture Partners' Kan Chen: Investing in Insilico Medicine four years before OpenAI went mainstream, AIDD platform has broad prospects
After completing its investment in Insilico Medicine, Qiming Venture Partners provided the company with sustained support and substantial assistance.
Qiming Venture Partners and Duane Kuang Win Shanghai Securities News 2025 Eagle Award for Finance
Select the institutions with outstanding annual performance
Qiming Venture Partners ESG | Qiming Venture Partners Rural Revitalization Entrepreneurship Support Program Selected as Global Best Poverty Reduction Case
Telling the world vivid stories of China's rural revitalization
Qiming Weekly | Qiming Venture Partners Portfolio News and Updates Vol. 45, 2025
Following the milestones of Qiming Venture Partners' portfolio companies, together with you.
Morning Star｜Noitom Robotics Closes Pre-A+ Round Led by Qiming Venture Partners
is a data company serving the Embodied Artificial Intelligence and humanoid robotics industry
Qiming Venture Partners co-leads $30M Series B in Shenzhen Oculgen, first-in-class bispecific OCUL101 enters Phase II in China and US
Focused on R&D of innovative ophthalmic drugs
Qiming Weekly | Qiming Venture Partners Portfolio News and Updates Vol. 44, 2025
Celebrating milestone moments with Qiming Venture Partners' portfolio companies
Qiming Venture Partners Wins Three Awards at China Securities Journal's 9th Private Equity Golden Bull Awards
The China Securities Journal's 9th Annual Golden Bull Awards for Equity Investment continue to spotlight "patient capital," emphasizing long-term value investing and hard-tech innovation while exploring diversified fund exit pathways.
Qiming Venture Partners and Duane Kuang Named to Jazzyear 2025 China Tech Industry Investment Rankings
The list aims to recognize investors and investment firms with outstanding performance and strong growth momentum in 2025, who have exerted profound influence on the development of China's tech industry.
Qiming Weekly | Qiming Venture Partners Portfolio News and Updates Vol. 43, 2025
Staying with you through the milestone moments of Qiming Venture Partners' portfolio companies
Morning Star | Over 20 Qiming Venture Partners Portfolio Companies Win 30 Awards in Zero2IPO's 2025 VENTURE50
The VENTURE50 rankings are China's bellwether for high-growth enterprise investment.
Qiming Venture Partners Wins 36Kr 2025 China Best ESG Investment Firm
ESG has become a powerful anchor for venture capital firms seeking certainty and reshaping value.
Qiming Weekly | Qiming Venture Partners Portfolio News and Updates Vol. 42, 2025
Staying with you through the milestone moments of Qiming Venture Partners' portfolio companies.
Qiming Venture Partners Named to Yicai CFV Top 10 Equity Investment Firms
Financial value is the synthesis of institutional competitiveness, product innovation, human capital, and risk management within the financial industry and markets. It also serves as the micro-foundation for a nation's overall financial strength and stability.
Qiming Venture Partners' Duane Kuang: Hong Kong Has Become a Key International Financing Channel for Hard-Tech Companies
Today, if companies are "born global," investment firms must evolve into institutions that are "born global" too.
Qiming Weekly | Qiming Venture Partners Portfolio News and Updates Vol. 40, 2025
Celebrating milestone moments with Qiming Venture Partners' portfolio companies
Morning Star | Eight Qiming Venture Partners Portfolio Companies Named to QbitAI Research Institute's 2025Q3 AI 100 Product Rankings
The flagship product list represents the leading players in the current landscape, while the innovation product list spotlights the seed candidates poised for future markets. Together, these two lists — spanning from comprehensive strength to breakthrough potential — sketch out a more three-dimensional and authentic map of AI products, offering industry participants and observers a set of reference-worthy benchmarks.
Yangli Pharma closes nine-figure RMB Series B round led by Qiming Venture Partners
Focused on developing first-in-class and best-in-class Class 1 innovative drugs with global intellectual property rights, with a focus on oncology and chronic disease therapeutics.
Qiming Star | Over 30 Qiming Venture Partners Portfolio Companies Named to 2025 China Biopharma Top 100 List
The compilation and release of the frontrunner rankings is a key initiative for identifying forward-looking trends, exploring the frontiers of technology, and establishing a "weather vane" for industry development.
Aureka Biotechnologies Closes Tens of Millions of Dollars in Series A Funding to Accelerate AI-Powered Antibody Design and Innovative Pipeline R&D
A biotech company focused on generative AI-powered antibody drug development
Qiming Star | Changsen Pharma Raises Hundreds of Millions of Yuan in Series B+ Funding to Accelerate Clinical Research and Global Expansion of Core Pipeline
Changsen Pharma is dedicated to independently developing first-in-class, best-in-class innovative drugs with global intellectual property rights to address unmet clinical needs.
Beware of Fake VC Scams
"Private funds raise capital only from specific qualified investors who meet certain criteria." Qiming Venture Partners reminds all investors and entrepreneurs to stay vigilant, verify authenticity, and avoid financial losses.
Morning Star | WeRide Showcases L4 Autonomous Driving Scale at 2025 World Intelligent Connected Vehicles Conference
WeRide has always made safety its highest priority, embedding it into every step of technology R&D, testing and validation, and daily operations.
Qiming Venture Partners Portfolio Companies Make 2025 Beijing Top 100 Private Enterprise Rankings
The list aims to highlight trends in Beijing's private-sector economy and industrial distribution, identify a cohort of high-quality private enterprises that align with the "high-end, precision, and cutting-edge" economic structure and demonstrate leading, exemplary, and driving effects, and encourage and guide private enterprises in practicing new development concepts to promote high-quality growth.
Qiming Venture Partners | iMile CEO Rita Huang: Winning Cross-Border Logistics Through Systems
iMile aims to become a truly global logistics technology company. Not through simple business expansion, but by leveraging technology to rapidly integrate with local ecosystems in every market and deliver standardized, high-quality services.
Qiming Venture Partners Weekly | Portfolio Company Updates and Funding News Vol. 37, 2025
Staying with you through the milestone moments of Qiming Venture Partners' portfolio companies
Qiming Venture Partners Wins Three Awards at China Venture Capital Research Institute's 2025 Golden Investment Awards
The awards aim to comprehensively recognize investment institutions that have achieved outstanding success in driving industry progress and creating social value over the past year.
Qiming Venture Partners Portfolio Company Yunji Technology Debuts on Hong Kong Stock Exchange
In 2021, Qiming Venture Partners led the Series C round for Yunji Technology and continued to support the company's growth in subsequent funding rounds.
Qiming Venture Partners Weekly | Portfolio Company Funding and Updates Roundup Vol. 36, 2025
Celebrating milestone moments with Qiming Venture Partners' portfolio companies
Qiming Venture Partners Portfolio Company Tashi Zhihang Unveils World's First Scalable Real-World Embodied Multimodal Dataset WIYH
This achievement marks the formal establishment of Tashi Zhihang's industry-first human-centric embodied data engine paradigm — a technical approach that leads Tesla's Optimus by roughly six months.
Qiming Venture Partners Solely Leads Makera's Pre-A Round, Ushering in a New Era of Accessible Precision CNC Tools
Maker Era is a technology company dedicated to providing intelligent, user-friendly precision CNC tools for makers, small and medium-sized enterprises, and educational institutions worldwide.
Qiming Venture Partners Named to Tech Pioneer T50 — China's Top 50 Vanguard Tech Investment Institutions
The ranking aims to strengthen industry consensus around the commercialization of early-stage technology, guiding investment institutions to more precisely align with the strategies of "investing early and small," nurturing innovation across the full sci-tech lifecycle, and channeling capital toward strategic emerging industries.
Qiming Venture Partners | WeRide Enters Ras Al Khaimah, UAE, Launching Robotaxi and Robobus Trial Operations
This marks the formal integration of WeRide's autonomous vehicles into the local public transportation system, paving the way for larger-scale commercial deployment of the company's autonomous driving products in the UAE.
Qiming Venture Partners Wishes You a Happy Mid-Autumn Festival!
The bright moon fills the vast heavens, and a journey of ten thousand li begins.
Qiming Venture Partners Named Top VC Fund in Yangtze River Delta Region by China FOF Research Center
The awards aim to recognize outstanding institutions in the private equity fund-of-funds and fund industries across the Yangtze River Delta region, and to promote the healthy development of the equity investment sector.
Qiming Weekly | Qiming Venture Partners Portfolio Funding and Updates Vol. 35, 2025
Staying with you through milestone moments at Qiming Venture Partners portfolio companies
Qiming Stars | Seven-Nation Permit, World's Only! WeRide Robobus Secures Belgium's First L4 Autonomous Driving License
As an autonomous driving technology company, WeRide's ultimate goal has always been to achieve safe and reliable Level 4 fully driverless operations. Securing the Belgium autonomous driving test permit is a critical step toward this goal, demonstrating the company's technical capabilities in real-world road scenarios and setting a benchmark for more European countries to open up autonomous driving testing.
AusperBio raises $63M in Series B2 funding co-led by Qiming Venture Partners
Haibo Pharmaceutical is a clinical-stage innovative drug company focused on the R&D of self-developed targeted small nucleic acid therapeutics, with "achieving clinical cure for chronic hepatitis B" as its core mission.
Qiming Venture Partners and Its Investors Named to 36Kr's 2025 China Industrial Investors Annual List
The list aims to identify investment firms and investors who embrace patience and foresight, and who are putting their convictions into practice to inject the strongest possible momentum into industries of the future.
Qiming Venture Partners Weekly | Portfolio Company Updates Vol. 34, 2025
Tracking milestone moments with you for Qiming Venture Partners' portfolio companies
Qiming Venture Partners' Portfolio Company Hesai Technology Completes Dual Primary Listing on Hong Kong Exchanges and Clearing Limited
Qiming Venture Partners has long paid close attention to innovation and transformation in the autonomous driving space. In 2019, Qiming Venture Partners participated in Hesai Technology's Series C financing and continued to invest in its Series D round.
Qiming Venture Partners' William Hu: From 'Chasing Concepts' to 'Evaluating Global Data,' China's Pharma Innovation and Investment Logic Is Being Rebuilt
Qiming Venture Partners will continue to support the development of China's innovative pharmaceutical companies, helping Chinese innovation reach the global stage — in other words, "China Innovation, Global Value."
Qiming Portfolio Company Yanyin Technology Partners with HEC Pharm on Strategic AI Collaboration
The two parties will engage in in-depth collaboration on AI agent R&D, using the AI translation agent project as a starting point to develop solutions covering core scenarios including experimental design and IND filing, as well as AI laboratory automation robotics. Together, they will explore the deep application of AI technology across the full drug discovery and development pipeline, accelerating the globalization strategy of East Sunshine Pharmaceutical.
Qiming Venture Partners' Mao Shuo Named to 2025 Mid-Year U40 Outstanding Young Investors List
The awards aim to recognize all young professionals with sharp instincts and strong expertise.
Morning Star | Cornerstone Robotics' Guowei Ou: Committed to Full-Stack Self-Development, Aiming to Transform the Global Surgical Robotics Landscape
To succeed as a founder, you need to balance two roles: the architect and the farmer. The architect takes the high-level view, designing efficient systems and setting strategic direction for the company. The farmer puts in the steady, unglamorous work — tilling the soil day after day, staying ready for bigger opportunities when they arrive.
Qiming Weekly | Qiming Venture Partners Portfolio News & Updates Vol. 33, 2025
Celebrating milestone moments with you at Qiming Venture Partners' portfolio companies
Qiming Venture Partners and Six Portfolio Companies Named to 2025 Investment Institution Soft Power Rankings
By constructing a localized private equity valuation framework, FOFWEEKLY aims to advance industry standardization and ultimately establish industry benchmarks that carry social-value leadership.
Qiming Venture Partners and Founding Managing Partner Duane Kuang Named to Touzijia 2025 China Fund Partners Annual List
The list aims to recognize investment institutions and individual investors who have demonstrated sustained commitment and achieved outstanding results in the equity investment industry over the past year, collectively bearing witness to the industry's moments of glory.
Qiming Venture Partners Portfolio Company UBTECH Lands $250 Million Humanoid Robot Order, Setting New Global Single-Contract Record
UBTECH has partnered with well-known companies in new energy vehicle manufacturing, 3C manufacturing, and smart logistics. Its industrial humanoid robot, the Walker S series, has become the humanoid robot deployed for training in the largest number of factories globally.
Qiming Venture Partners' WeRide Sends First Robotaxi GXR Fleet to Singapore for Testing
WeRide, a global leader in Robotaxi commercialization, has deployed, tested, and operated in four countries — China, the UAE, Saudi Arabia, and Switzerland — achieving a safety record of over 2,200 consecutive days.
Qiming Stars | WeRide and Shenzhen Bus Group Launch B888 Autonomous Bus Route
As Shenzhen's first L4 autonomous bus route cutting through a bustling central business district, the new B888 line faces an extraordinarily complex traffic environment. Safely and efficiently navigating dense streams of motor vehicles, non-motorized traffic, and pedestrians represents a high-caliber demonstration of WeRide's autonomous driving technology.
Qiming Venture Partners and Executive Director Mao Shuo Named to TMTpost's 2025 H1 Pioneer Rankings
The venture capital world is flourishing in a more diverse and dynamic direction.
Qiming Venture Partners and Multiple Portfolio Companies Named to Jazzyear's 2024-2025 China Tech Industry Investment Rankings
The list aims to recognize outstanding investment institutions, investors, and science and technology innovation enterprises that have made significant contributions to the development of China's tech industry.
Qiming Venture Partners Portfolio Company WeRide Named to 2025 Wealth China Tech 50 List
The list aims to identify tech companies born in China that are shaping the world. Their success lies not merely in specific technologies or products, but in the innovative spirit and global vision they represent.
Qiming Venture Partners Weekly | Portfolio Company Updates Vol. 31, 2025
Celebrating milestone moments with Qiming Venture Partners' portfolio companies
Morning Star | SANY Hydrogen Raises Hundreds of Millions of RMB in Series A Funding Led by Qiming Venture Partners
SANY Hydrogen is the hydrogen energy strategic platform built by SANY Heavy Industry, a global leader in equipment manufacturing, to advance China's "dual carbon" goals.
Qiming Star | Video Rebirth's Wei Liu: Video Generation Models Are the Optimal Path to Building World Models
Video Rebirth defines the video-native world model as a combination of a world simulator and a world predictor.
Qiming Star | Under Mayo Clinic Guidance, SinoUnited Health Launches Longevity Clinic, Pioneering Medical-Grade Longevity Management via Multidisciplinary Care and Digital Platform
Internationally standardized, medical-grade longevity medicine protocols
Qiming Headlines | US$200 Million Qishun QFLP Project Launches in Kunshan
Qiming Weekly | Qiming Venture Partners Portfolio News and Updates Vol. 30, 2025
Celebrating milestone moments with Qiming Venture Partners' portfolio companies
Qiming Star | Yuaiweiwu CEO Huaiting Zhang: To Build an AI Application Startup, First Close the Business Loop, Then Let the Model Take Over
The entrepreneurial opportunity in AI applications lies in using generative AI to transform services into manufacturing.
Q&A | Qiming Venture Partners' Wang Shiyu and Future Intelligent's Ma Xiao on Building Truly Valuable AI Hardware
In the large-model era, data accumulation and deep cultivation of vertical scenarios are the core moats for startups. Future Intelligent will build a "perception + workflow closed loop" office ecosystem through hardware entry points, forming differentiated competition with tech giants.
Rongzi China's Zhu Shan and Qiming Venture Partners' Duane Kuang on AI as the Biggest Paradigm Shift and the Next Generation of Classic Investment Cases
Despite the fierce competition in tech today, many niche segments remain underexplored. The AI space will give rise to ecosystem players on the scale of Xiaomi, creating new opportunities for both industry giants and startups.
Minghui Pharmaceutical Raises $131M in Pre-IPO Round Co-Led by Qiming Venture Partners
Minghui Pharmaceutical is a late-stage biopharmaceutical company focused on oncology and autoimmune diseases.
Qiming Venture Partners' Portfolio Company WeRide Kicks Off 24/7 Stress Testing in Beijing
WeRide is among the first autonomous driving companies approved to conduct nighttime road tests in Beijing, marking a critical step toward building a "7×24" autonomous driving service network in the city and laying a solid foundation for truly round-the-clock autonomous mobility services.
Qiming Venture Partners Portfolio Companies Shine at 2025 World Artificial Intelligence Conference
As one of the most influential industry events in the global artificial intelligence sector, the 2025 World Artificial Intelligence Conference took "Intelligent Era: Shared Responsibility for Our Planet" as its theme, continuing to serve its important roles as a "technology weathervane, application showcase, industry accelerator, and governance forum" — comprehensively presenting the latest developments in cutting-edge AI technology, industrial trends, and global governance practices.
Qiming Weekly | Qiming Venture Partners Portfolio Companies: Funding and Updates Vol. 28, 2025
Staying with you through the milestone moments of Qiming Venture Partners' portfolio companies.
Q&A | Duane Kuang and Qianli Technology's Qi Yin: Closed-Loop Business Models Sustain Tech Progress, AI Era Offers Huge Hardware Opportunities
Because of the changes brought by AI Agent assistants and operating systems, many different hardware form factors will emerge in the future before gradually converging. This is a space where both tech giants and startups will have significant opportunities.
Evolutionary Tide Raises Hundreds of Millions of Yuan in Pre-A Round, Qiming Venture Partners Co-Leads
Emergent Tide is built on original research from the Tsinghua University School of Medicine team in the field of humoral immunity, developing novel therapeutics for inflammatory and autoimmune diseases against a first-in-class global target, addressing core challenges in the field and significant unmet clinical needs.
Qiming Stars | Three CEOs of Qiming Venture Partners Portfolio Companies Named 2025 AI Figures of the Year
Awards showcase the latest practices, fruitful achievements, and broad prospects of China's AI sector.
Qiming View: Technology Grows Upward, Applications Take Root Downward — Releasing the AI Resonance Cycle and Top 10 AI Predictions for 2025
This year, AI has entered a "resonance cycle of technology and application." On one hand, the technology continues to grow rapidly upward with no obvious ceiling in sight. On the other hand, it has become "good enough" in terms of performance and cost for large-scale deployment to take root and grow solidly, like tree roots digging deep — creating massive value in the process.
Qiming Headlines | 2025 WAIC "Qiming Venture Partners · Entrepreneurship and Investment Forum—Venture Capital Ignites the AI Technology and Application Resonance Cycle" Successfully Held
From AI 1.0 to AI 2.0, Qiming Venture Partners has invested in over 100 AI projects, with portfolio companies spanning the entire AI industry chain. The firm has helped catalyze the rise of multiple sector-defining companies and stands as one of the most active and influential investment institutions in artificial intelligence across China and Asia.
Qiming Venture Partners Weekly | Portfolio Company Updates Vol. 27, 2025
Celebrating milestone moments with Qiming Venture Partners' portfolio companies
2 Days to Go: Qiming Venture Partners' 2025 WAIC Entrepreneurship and Investment Forum — Venture Capital Enters a Resonance Cycle of AI Technology and Applications
This sub-forum will showcase and explore the latest breakthroughs in AI technology and applications through an innovation lens. Qiming Venture Partners will bring together leading scholars and pioneering entrepreneurs in the field — from both the startup and investment perspectives — for four keynote speeches and four panel discussions.
Qiming Venture Partners' Portfolio Shines with 10+ Companies on 2025 AI Cloud 100 China List
The ranking aims to identify Cloud companies that have achieved genuine commercial deployment in generative AI (GenAI) and delivered significant economic returns.
Qiming Venture Partners and Four Portfolio Founders Named to Cyzone's 2025 Under-40 Investors and Under-35 Entrepreneur Lists
The Under-40 Investors list seeks out the capital scouts who are active on the front lines of venture capital and steadily riding the crest of the wave; the Under-35 Entrepreneur Pioneers list spotlights and energizes a new generation of young talent, capturing the most vibrant pulse of innovation in our era — serving as a vital barometer for spotting tomorrow's business leaders and innovation trends.
WeRide Teams Up With Lenovo Vehicle Computing to Globally Debut 100% Automotive-Grade HPC 3.0 Computing Platform Powered by NVIDIA DRIVE Thor
Going forward, WeRide will also apply the HPC 3.0 platform to its other L4 autonomous driving products, including autonomous minibuses and sanitation vehicles, making autonomous driving technology accessible across all urban scenarios and serving more customers and users.
Qiming Weekly | Qiming Venture Partners Portfolio News and Updates Vol. 26, 2025
Join us in spotlighting milestone moments for companies in Qiming Venture Partners' portfolio.
Qiming View | William Hu: China's Innovative Drug Industry Is Experiencing a Collective Breakthrough
Qiming Venture Partners' current investment focus is on driving China's innovation onto the global stage and making it an integral part of the worldwide innovation ecosystem.
Qiming Venture Partners Portfolio Companies Named Beijing Digital Economy Benchmark Enterprises
Benchmark enterprises not only drive core growth but also demonstrate and catalyze the shared development of upstream and downstream partners, advancing high-quality growth in the digital economy.
Guest Lineup Revealed | Register Now for 2025 WAIC Qiming Venture Partners · Entrepreneurship and Investment Forum — Venture Capital Enters AI Technology and Application Resonance Cycle
This sub-forum will showcase and explore the latest breakthroughs in AI technology and applications through the lens of innovation. Qiming Venture Partners will bring together leading scholars and top entrepreneurs in the field — from both the startup and investment perspectives — for four keynote speeches and four panel discussions.
Dialogue | Building Surgical Robots at the 'Tip of the Pyramid'
The R&D of surgical robots demands high standards and presents significant technical challenges. Cornerstone Robotics has built a foundation of safety and stability through independent R&D and a high degree of domestic sourcing, with outstanding clinical trial results demonstrating that its products have reached world-class levels.
Agenda Revealed | 2025 WAIC Qiming Venture Partners Entrepreneurship and Investment Forum: Venture Capital Enters a Resonance Cycle of AI Technology and Applications
This sub-forum will showcase and explore the latest breakthroughs in AI technology and applications through the lens of innovation. Qiming Venture Partners will bring together leading scholars and pioneering entrepreneurs in the field — from both the startup and investment perspectives — for four keynote speeches and four panel discussions.
Qiming Venture Partners Portfolio Companies Shine on 2025 China Globalization Rising Stars 100 List
The ranking focuses on companies that achieved at least $10 million in overseas revenue in 2024, as well as companies that have already generated overseas revenue to date and possess strategic deployment capabilities in the global market.
Dialogue | A New Paradigm for the Globalization of Chinese Tech Brands
Insisting on in-house R&D of core components not only ensures a leading edge in product technology and reliability, but also cultivates a corporate culture of independent innovation. The company remains committed to an internationalization strategy, aiming to achieve 60% of sales from overseas markets before 2030. It continues to pursue intelligentization as a strategic direction.
Interview | 'AI + Hardware': Insta360's JK on Keeping the Originality Flywheel Spinning
Companies need to solve users' genuinely unmet needs through continuous technological innovation, then reinvest profits into the next round of R&D — creating a virtuous cycle where innovation drives growth.
Qiming Stars | Multiple Qiming Venture Partners Portfolio Companies Appear at 2025 Summer Davos Forum
As a dialogue platform hailed as a "barometer of the world economy," the Summer Davos Forum brings together global leaders, innovators, and changemakers to tackle pressing economic challenges and explore new frontiers of sustainable and inclusive growth.
Qiming Weekly | Qiming Venture Partners Portfolio News and Updates Vol. 24, 2025
Following Qiming Venture Partners' portfolio companies and their milestone moments with you
Forum Registration Open | 2025 WAIC Qiming Venture Partners Entrepreneurship and Investment Forum: Venture Capital Enters AI Technology and Application Resonance Cycle
The forum will focus on the most promising AI sub-sectors today, featuring a rich agenda including portfolio company showcases, industry panel discussions, and investment insights from Qiming Venture Partners. It aims to help AI entrepreneurs and investors seize the explosive growth opportunities of the intelligent era and jointly drive the evolution and advancement of the AI industry.
Qiming Star | Infinigence AI's Yu Wang: Exploring the Next Frontier of Edge Intelligence
The future of edge intelligence requires a two-way commitment between academia and industry. Only when hardware innovation and algorithmic breakthroughs form a closed loop can we truly unlock AI's potential to transform the physical world.
Qiming Venture Partners' Duane Kuang, William Hu, and Alex Zhou Named to PEDaily's 2025 TOP100 Investors List
The awards have been held for ten consecutive editions, becoming a window into observing industry shifts, with the aim of selecting 100 outstanding investors who have delivered strong investment performance while also driving progress in China's venture capital landscape.
Qiming Weekly | Qiming Venture Partners Portfolio Companies Funding and Updates Vol. 23, 2025
Celebrating milestone moments with Qiming Venture Partners' portfolio companies
Qiming Venture Partners Portfolio Companies Xiaomi, Insta360, and Roborock Named to 2025 Kantar BrandZ Top 50 Chinese Global Brands
Rankings not only clearly demonstrate the continued rise of Chinese brands' influence in the globalization process, but also provide the industry with an authoritative perspective for understanding the competitive landscape of global markets.
Qiming Perspective | William Hu on the Ecosystem Logic Behind Innovative Drug M&A Integration
In this era of transformation, Qiming Venture Partners places greater emphasis on whether a company's technology and products achieve genuine breakthroughs, and whether it can deliver clinical value that others cannot. Qiming Venture Partners supports enterprises that bring tangible benefits to patients.
Qiming Venture Partners Weekly | Portfolio Company Updates and Funding News Vol. 22, 2025
Following Qiming Venture Partners' portfolio companies' milestone moments with you
Qiming Stars | Three Qiming Venture Partners Portfolio Companies Selected for 2025 Ifenxi AIGC Vendor Panorama Report
The report aims to reveal how generative AI technology is being applied in specific domains and the core competitive strengths of representative vendors.
Qiming Venture Partners Weekly | Portfolio Company Updates and Funding News Vol. 21, 2025
Celebrating milestone moments with Qiming Venture Partners' portfolio companies
Qiming Venture Partners and Four Portfolio Companies Win 2025 Sci-Tech Innovation Golden Bull Awards
The "Golden Bull Award" is one of the most influential honors in China's capital markets. The Sci-Tech Innovation Golden Bull Award aims to showcase outstanding listed and unlisted companies in strategic emerging industries, while also recognizing the patient capital that diligently supports the rise of new high-tech enterprises.
Qiming Venture Partners and Its Investors Named to 36Kr's 2025 China Equity Investment Industry Lists
Investment firms focused on technological innovation are well-positioned to stand out in this wave of industrial upgrading.
Qiming Venture Partners' Ted Ye: Insta360's Decade of Dedication Unlocks Huge Potential for 'Imaging + AI'
Qiming Venture Partners firmly believes that hard tech is the true driver of industrial transformation, and places great trust in young entrepreneurs.
Morning Star | Global smart-imaging leader Insta360 debuts on STAR Market
As an early investor in Insta360, Qiming Venture Partners has accompanied the company through a decade-long journey. Back in 2015, Qiming Venture Partners led Insta360's Series B round, and continued to support the company's growth in its Series C financing.
Morning Star | Five Qiming Venture Partners Portfolio Companies Named to BEYOND Awards MedTech Transcendence and Health Leadership Lists
The BEYOND Awards Medical Technology Transcendence List seeks to identify and honor the transcendent forces in medical technology that demonstrate exceptional innovation capabilities and achieve "defining industry top standards"; the Great Health Navigation List focuses on leading enterprises that truly meet consumer health needs and exhibit strong growth potential and outstanding innovation capabilities.
Morning Star | DeepWay: The New Energy Heavy-Duty Truck of the Future Is Essentially an Industrial Robot
Staying committed to in-house R&D and production of core components, pursuing an internationalization strategy, and maintaining investment and iteration in intelligent technologies.
Qiming Venture Partners | WeRide teams up with Renault again to provide autonomous shuttle service for French Open
As a key component of Europe's green low-carbon public transit transition strategy, WeRide and the Renault Group have conducted autonomous minibus testing and operations in Paris, the southern French city of Valence, and the Spanish capital of Barcelona, continuously expanding the reach and impact of autonomous driving technology across Europe.
Qiming Star | Hesai Technology's David Li: Focus on In-House High-Performance Products and Continuously Improve Operational Efficiency
Each generation of products demands radical innovation and heavy upfront investment to strike a balance between lower costs and high performance.
Qiming Weekly | Qiming Venture Partners Portfolio News and Updates Vol. 19, 2025
Join us in celebrating milestone moments from Qiming Venture Partners' portfolio companies
Qiming Star | Tianchen Biotech Raises Over 200 Million Yuan in Series C, Co-Led by Qiming Venture Partners
TianChen Bio is committed to setting the industry benchmark in allergic diseases and complement-mediated diseases, continuously driving treatment innovation to deliver breakthrough therapies with greater clinical value and accessibility for patients worldwide.
Qiming Venture Partners portfolio company WeRide enters Saudi market with three products deployed
As its first step into the Saudi market, WeRide has tested and deployed autonomous driving products including Robotaxi, Robobus, and Robosweeper in key Saudi cities such as Riyadh and AlUla, laying the groundwork for J&T Global Express's subsequent large-scale commercial operations across the entire Kingdom.
Qiming Weekly | Qiming Venture Partners Portfolio Companies: Funding and Updates Vol. 18, 2025
Staying with you through milestone moments for Qiming Venture Partners' portfolio companies
Morning Star | Jieti Medical: The Value of Brain-Computer Interfaces Is Greater Than Imagined, Aiming to Rival Elon Musk's Neuralink
To capture this hundred-billion-yuan brain-computer interface market, system development must be application-value driven, implemented according to clinical standards, and ultimately achieve commercialization.
Qiming Venture Partners' Duane Kuang: China's new quality productive forces are going global, and the venture capital industry can play an important role
Venture capital firms' tolerance for high risk and focus on long-term value inherently make them adventurous, willing to back technological innovation. By building a closed innovation loop that moves from "blood transfusion" to "blood creation," they can deeply embed themselves in company growth. And they have the ability to identify the most promising entrepreneurs and the most compelling directions for innovation.
Qiming Venture Partners Portfolio Company WeRide Deepens Strategic Partnership with Tencent Cloud to Expand Robotaxi Commercial Operations and Overseas Markets
WeRide and Tencent Cloud will deepen their integration of strengths to jointly build a new generation of data-driven autonomous driving cloud platforms, connecting the full R&D, testing, and operations workflow to create an innovation flywheel for autonomous driving and accelerate the scaled commercialization of Robotaxi and other autonomous driving products.
Morning Star | Four Qiming Venture Partners Portfolio Companies Selected for S&P Global Sustainability Yearbook (China Edition) 2025
The Yearbook aims to identify and recognize Chinese companies that have demonstrated sustainable development advantages in industries such as biotechnology, healthcare, machinery and electrical equipment, automotive manufacturing, and communications equipment.
Qiming Weekly | Qiming Venture Partners Portfolio News and Updates Vol. 17, 2025
Celebrating milestone moments with Qiming Venture Partners' portfolio companies
Qiming Star | CANbridge Pharma's velaglucerase alfa for injection (brand name: Gerining), a first-in-class drug for Type I and Type III Gaucher disease, approved for market launch in China
Gorenicin is not only the third rare disease treatment drug launched by CANbridge after Hymricin and Myrbetriq, but also the first self-developed product poised for commercialization.
Qiming Stars | Three Qiming Venture Partners Portfolio Companies Named to KPMG China Biotech Innovation 50 List
These awards do more than give industry leaders a stage to showcase their achievements — they offer a deep reflection on the innovative resilience and growth potential of China's biotech sector.
Qiming Weekly | Qiming Venture Partners Portfolio News and Updates Vol. 16, 2025
Celebrating milestone moments with Qiming Venture Partners' portfolio companies
Qiming View | Duane Kuang: The Time Is Ripe for Chinese Tech to Go Global
China's technology going global — the time is now. In the coming years, all kinds of our AI-related technologies will join this wave of going global as well. The trend of Chinese technology expanding worldwide is only just beginning.
Qiming Venture Partners and 50+ portfolio companies named to 2025 Future Healthcare 100 list
These rankings and reports aim to document the year's industry breakthroughs and reveal the growth patterns of listed companies and evolving industry trends, offering a reference for healthcare enterprises and entrepreneurs.
Qiming Spotlight | Over 10 Qiming Venture Partners Portfolio Companies Named to Star 100 · 2025 China AI Industry Wave Makers List
The rankings confirm AI technology's evolution from technical exploration to the deep waters of industry application, while also showcasing Chinese companies' technical strength and growth potential.
Multiple Qiming Venture Partners Portfolio Companies Win Touzijia 2025 Robot Industry Conference Gold Flint Awards
The award aims to uncover companies and entrepreneurs in the robotics industry who dare to take on challenges and strive for success against adversity.
Qiming Venture Partners Portfolio Companies Participate in 21st Shanghai International Auto Show
The 2025 Shanghai Auto Show marked a milestone in the Chinese auto industry's march toward globalization, with China's relentlessly charged innovative energy opening up fresh growth space for the global automotive industry.
Qiming Perspective | Duane Kuang: AI Investment Outlook Is Broad
2025 will mark an inflection point for AI applications. In the AI 2.0 era, investment in AI infrastructure still has significant room to grow, explosive growth in AI applications is on the horizon, and the investment landscape for AI applications will become increasingly diverse and vibrant.
Qiming Venture Partners portfolio company WeRide expands strategic partnership with Uber, bringing autonomous Robotaxi service to 15 new cities globally
The cross-continental new city expansion plan demonstrates WeRide and Uber's confidence in each other's technology, as well as their shared pursuit of innovative, sustainable transportation solutions.
Xi Jinping Inspects Shanghai’s Model Speedway, StepFun and Infinigence AI Give Key Presentations
AI technology is accelerating through iteration cycles and entering a phase of explosive growth.
Qiming Venture Partners Portfolio Companies Zhipu AI and Shengshu Technology Forge Strategic Partnership to Advance Domestic Large Model Innovation and Industrial Deployment
The two parties will jointly explore forward-looking AI technology innovations and collaborate to empower intelligent transformation across all industries.
Qiming Venture Partners Portfolio Company WeRide Launches "WeRide Mobility" App
In addition to its self-operated mobility service platform, WeRide also partners with local operators in multiple locations worldwide to provide Robotaxi and Robobus services.
Morning Star | Over 20 Qiming Venture Partners Portfolio Companies Named to 2025 China Future Unicorn Top 100 and Other Lists
The selection process isn't just a deep dive into innovative companies — it also gives investors a chance to spot potential winners.
Qiming Stars | GYENNO Science CEO Ren Kang: Using AI to Cut Through the "Thousand Faces, Thousand Cases" Fog of Parkinson's Disease
In the field of neurodegenerative diseases, true technical breakthroughs don't come from the elegance of any single algorithm, but from the systematic deconstruction and reconstruction of the disease itself.
Qiming Venture Partners Wins LP Advisory's 2024 Top 3 Venture Capital Firm Award
The ranking aims to reveal the actual exit performance of VC/PE funds and institutions, serving as a critical data benchmark for LPs to evaluate fund performance and institutional investment capabilities.
Qiming Star | ZuoYi Tech CEO Zhang Chao: Using AI Doctors to Fill the 'Blank Spaces' in the Healthcare Ecosystem
Zuo Yi Technology's future roadmap centers on "proactive artificial intelligence." An AI doctor should not merely be a tool that responds passively, but rather an active health partner that intervenes on its own initiative.
Future Intelligent Raises Tens of Millions of RMB in Pre-A+ Round, Co-Led by Qiming Venture Partners
Future Intelligent focuses on R&D and scenario innovation for AI-powered office hardware.
Qiming Venture Partners Weekly | Portfolio News and Updates Vol. 14, 2025
Celebrating milestone moments with Qiming Venture Partners' portfolio companies
Qiming Venture Partners Portfolio Companies Featured in QbitAI 2025 AIGC Companies and Products List
The ranking aims to offer an objective lens for understanding application trends in China's generative AI space, spotlighting early adopters and benchmark cases that dare to experiment and innovate.
Qiming Venture Partners and Portfolio Companies Win Multiple ChinaVenture Awards, Including Top 5 China VC Firm of 2024
The "ChinaVenture Rankings" have been published for 19 consecutive years, recognized within the industry for their professionalism, authority, and rigor. They are widely regarded as a bellwether for China's equity investment sector and serve as a key reference for capital commitments from many large institutional LPs.
Qiming Star | Ark Biosciences Announces Latest Research Results for First RSV-Specific Antiviral Drug Ziresovir Published in The Lancet Child & Adolescent Health | Bilingual
This study, the world's first Phase 3 clinical trial covering RSV-infected infants under six months of age, successfully fills the evidence gap for targeted treatment approaches in this high-risk population and provides critical evidence for building a comprehensive RSV disease management system.
Qiming Venture Partners Portfolio Companies Dominate China AI Top 300 List
The rankings prioritize technical capability and commercialization potential, offering a panoramic survey of China's systematic breakthroughs in AI technology.
Qiming Venture Partners and Founding Managing Partner Duane Kuang Named to 2024 List of World's Best Investment Institutions
The ranking reflects the influence of China's private equity market in the global investment industry.
Qiming Venture Partners portfolio company WeRide adopts BlackBerry QNX to build ultra-safe ADAS solution
By leveraging QNX's foundational software, WeRide has not only enhanced the performance of its driver-assistance systems, but also advanced autonomous vehicles as a core component of smart cities — easing traffic congestion, reducing carbon emissions, and improving road safety.
Qiming Star | Light Years Beyond's Qi Yuan: AI for Science Should Create Products Serving Thousands of Industries
The ultimate goal of AI for Science is to achieve an "AI Albert Einstein" — capable of discovering entirely new, unknown scientific laws. But before that ambitious vision becomes reality, a more practical target is to build an "AI Doraemon": a form of inclusive intelligence that can empower every industry and sector.
Qiming Venture Partners Weekly | Portfolio Company Updates and Funding News Vol. 12, 2025
Staying with you through the milestone moments of Qiming Venture Partners' portfolio companies
Qiming Venture Partners Portfolio Companies Dominate 2024 Tech High-Growth and Best CEO Rankings
The list aims to identify outstanding companies in China's tech sector that have captured capital market attention while earning recognition from customers and the market — high-tech, high-growth ventures with strong teams, solid reputations, and cross-cycle resilience. It also seeks to honor the best CEOs and best young CEOs who possess international vision, industry insight, and leadership capabilities to steer their enterprises into a new era.
Morning Star | Multiple Qiming Venture Partners Portfolio Companies Appear at 2025 Zhongguancun Forum Annual Conference and Win Multiple Awards
Since its founding, Qiming Venture Partners has focused on investing in exceptional early- and growth-stage companies driven by technology and innovation.
Qiming Venture Partners | WeRide secures French driverless permit, becoming the only autonomous driving tech company with licenses in five countries
From application to final approval, WeRide and beti took just three months — a record for autonomous driving companies obtaining permits in France. It also means WeRide has met the highest standards in Europe for technical safety validation and operational program design.
Qiming Star | WeRide's Han Xu: The Ultimate Winner Will Prevail on Service Quality | Bilingual
WeRide is an international company dedicated to bringing autonomous driving services to the global market. The company is building a robust business development team and sales network, while developing a universal autonomous driving technology platform to support operations and services worldwide.
Qiming Weekly | Qiming Venture Partners Portfolio News and Updates Vol. 10, 2025
Celebrating milestone moments with Qiming Venture Partners' portfolio companies
Qiming View | Duane Kuang: AI Is the Priority for Tech Investment, China's Engineering and Design Products Reach Globally
AI still has many niche areas and business models left to explore, and Qiming Venture Partners remains bullish on this direction in 2025.
Qiming Venture Partners' Alex Zhou: A 'Super AI App' Will Likely Emerge This Year
Use trend anticipation to gauge which stage a technology wave is currently in and what opportunities exist, positioning yourself ahead of the market before the technology's development prospects become widely recognized.
Qiming Venture Partners Weekly | Portfolio News and Updates Vol. 09, 2025
Celebrating milestone moments with Qiming Venture Partners' portfolio companies
Qiming Weekly | Qiming Venture Partners Portfolio News and Updates Vol. 08, 2025
Following Qiming Venture Partners' portfolio companies and their milestone moments with you.
Jihoo Tech's Chen Keqing: Driving Demand-Driven Product Development Through 'Algorithm + Chip' Dual-Engine Model
Jihao Technology's medium- to long-term plan builds on the established smartphone and tablet markets while targeting edge-side intelligent hardware, with a deep focus on innovating and applying AI in the consumer electronics market.
Qiming Portfolio | UBTECH Achieves World's First Multi-Robot, Multi-Scenario, Multi-Task Humanoid Collaborative Training
UBTECH has developed a novel BrainNet software architecture for humanoid robots and designed an Internet of Humanoids (IoH) as a smart connectivity hub, offering a viable path for the software and hardware implementation of collective intelligence.
Qiming Star | WeRide's Tony Han: Autonomous Driving Will 'Light Up' the World Like the Light Bulb | Bilingual
WeRide developed autonomous driving technology with the original intention of making transportation safer, more efficient, and more comfortable — and to bring this immensely useful technology to people around the world.
Qiming Weekly | Qiming Venture Partners Portfolio Funding and Updates Vol. 07, 2025
Celebrating milestone moments with Qiming Venture Partners' portfolio companies
Morning Star | Pulnovo Medical Raises Nearly $100 Million in Series C, Co-Led by Qiming Venture Partners | Bilingual
This round was oversubscribed twice, making it the largest market-driven financing in the Asia-Pacific innovative medical device sector in recent years.
